Waldencast price target lowered to $12 from $13 at Telsey Advisory

Telsey Advisory lowered the firm’s price target on Waldencast to $12 from $13 and keeps an Outperform rating on the shares following the FY22 results. Telsey continues to believe the global beauty market is attractive and resilient and that Waldencast is currently exposed to two of its most dynamic segments, clinical skincare and prestige, clean makeup, and that the company’s portfolio-approach strategy allows the company to flex into categories, the analyst tells investors in a research note.